Global Saliva-based Screening Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Saliva-based Screening Industry Forecast” looks at past sales and reviews total world Saliva-based Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected Saliva-based Screening sales for 2023 through 2029. With Saliva-based Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Saliva-based Screening industry.
This Insight Report provides a comprehensive analysis of the global Saliva-based Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Saliva-based Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Saliva-based Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Saliva-based Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Saliva-based Screening.
The global Saliva-based Screening market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Saliva-based Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Saliva-based Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Saliva-based Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Saliva-based Screening players cover Thermo Fisher scientific, Qiagen, Hologic, Takara Bio Inc, Arcis Biotechnology Limited, GeneProof, Abacus ALS, Chai Inc. and Kolplast Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Saliva-based Screening market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Saliva-based Screening Industry Forecast” looks at past sales and reviews total world Saliva-based Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected Saliva-based Screening sales for 2023 through 2029. With Saliva-based Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Saliva-based Screening industry.
This Insight Report provides a comprehensive analysis of the global Saliva-based Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Saliva-based Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Saliva-based Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Saliva-based Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Saliva-based Screening.
The global Saliva-based Screening market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Saliva-based Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Saliva-based Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Saliva-based Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Saliva-based Screening players cover Thermo Fisher scientific, Qiagen, Hologic, Takara Bio Inc, Arcis Biotechnology Limited, GeneProof, Abacus ALS, Chai Inc. and Kolplast Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Saliva-based Screening market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Direct Sample to PCR
- RT-qPCR
- Lateral Flow Assays
- Diagnostic Laboratories
- Hospitals & Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher scientific
- Qiagen
- Hologic
- Takara Bio Inc
- Arcis Biotechnology Limited
- GeneProof
- Abacus ALS
- Chai Inc.
- Kolplast Group
- Lucence Health INc
- Vitagene
- Therma Bright Inc
- ACON Laboratories, Inc
- TODA PHARMA
- Norgen Biotek Corp.
- Assure Tech. (Hangzhou) Co., Ltd
- Beijing Hotgen Biotech Co., Ltd
- Nantong Diagnos Biotechnology Co., Ltd
- NeuMoDx Molecular, Inc.
- KYODO INTERNATIONAL INC.
- Canvax
- Zymo Research Corporation.
- Salimetrics
- NEST Scientific USA
- Miraclean Technology Co. Ltd
- Mawi DNA Technologies
- Cell Projects Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Saliva-based Screening Market Size 2018-2029
2.1.2 Saliva-based Screening Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Saliva-based Screening Segment by Type
2.2.1 Direct Sample to PCR
2.2.2 RT-qPCR
2.2.3 Lateral Flow Assays
2.3 Saliva-based Screening Market Size by Type
2.3.1 Saliva-based Screening Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Saliva-based Screening Market Size Market Share by Type (2018-2023)
2.4 Saliva-based Screening Segment by Application
2.4.1 Diagnostic Laboratories
2.4.2 Hospitals & Clinics
2.4.3 Others
2.5 Saliva-based Screening Market Size by Application
2.5.1 Saliva-based Screening Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Saliva-based Screening Market Size Market Share by Application (2018-2023)
3 SALIVA-BASED SCREENING MARKET SIZE BY PLAYER
3.1 Saliva-based Screening Market Size Market Share by Players
3.1.1 Global Saliva-based Screening Revenue by Players (2018-2023)
3.1.2 Global Saliva-based Screening Revenue Market Share by Players (2018-2023)
3.2 Global Saliva-based Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SALIVA-BASED SCREENING BY REGIONS
4.1 Saliva-based Screening Market Size by Regions (2018-2023)
4.2 Americas Saliva-based Screening Market Size Growth (2018-2023)
4.3 APAC Saliva-based Screening Market Size Growth (2018-2023)
4.4 Europe Saliva-based Screening Market Size Growth (2018-2023)
4.5 Middle East & Africa Saliva-based Screening Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Saliva-based Screening Market Size by Country (2018-2023)
5.2 Americas Saliva-based Screening Market Size by Type (2018-2023)
5.3 Americas Saliva-based Screening Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Saliva-based Screening Market Size by Region (2018-2023)
6.2 APAC Saliva-based Screening Market Size by Type (2018-2023)
6.3 APAC Saliva-based Screening Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Saliva-based Screening by Country (2018-2023)
7.2 Europe Saliva-based Screening Market Size by Type (2018-2023)
7.3 Europe Saliva-based Screening Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Saliva-based Screening by Region (2018-2023)
8.2 Middle East & Africa Saliva-based Screening Market Size by Type (2018-2023)
8.3 Middle East & Africa Saliva-based Screening Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SALIVA-BASED SCREENING MARKET FORECAST
10.1 Global Saliva-based Screening Forecast by Regions (2024-2029)
10.1.1 Global Saliva-based Screening Forecast by Regions (2024-2029)
10.1.2 Americas Saliva-based Screening Forecast
10.1.3 APAC Saliva-based Screening Forecast
10.1.4 Europe Saliva-based Screening Forecast
10.1.5 Middle East & Africa Saliva-based Screening Forecast
10.2 Americas Saliva-based Screening Forecast by Country (2024-2029)
10.2.1 United States Saliva-based Screening Market Forecast
10.2.2 Canada Saliva-based Screening Market Forecast
10.2.3 Mexico Saliva-based Screening Market Forecast
10.2.4 Brazil Saliva-based Screening Market Forecast
10.3 APAC Saliva-based Screening Forecast by Region (2024-2029)
10.3.1 China Saliva-based Screening Market Forecast
10.3.2 Japan Saliva-based Screening Market Forecast
10.3.3 Korea Saliva-based Screening Market Forecast
10.3.4 Southeast Asia Saliva-based Screening Market Forecast
10.3.5 India Saliva-based Screening Market Forecast
10.3.6 Australia Saliva-based Screening Market Forecast
10.4 Europe Saliva-based Screening Forecast by Country (2024-2029)
10.4.1 Germany Saliva-based Screening Market Forecast
10.4.2 France Saliva-based Screening Market Forecast
10.4.3 UK Saliva-based Screening Market Forecast
10.4.4 Italy Saliva-based Screening Market Forecast
10.4.5 Russia Saliva-based Screening Market Forecast
10.5 Middle East & Africa Saliva-based Screening Forecast by Region (2024-2029)
10.5.1 Egypt Saliva-based Screening Market Forecast
10.5.2 South Africa Saliva-based Screening Market Forecast
10.5.3 Israel Saliva-based Screening Market Forecast
10.5.4 Turkey Saliva-based Screening Market Forecast
10.5.5 GCC Countries Saliva-based Screening Market Forecast
10.6 Global Saliva-based Screening Forecast by Type (2024-2029)
10.7 Global Saliva-based Screening Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher scientific
11.1.1 Thermo Fisher scientific Company Information
11.1.2 Thermo Fisher scientific Saliva-based Screening Product Offered
11.1.3 Thermo Fisher scientific Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Thermo Fisher scientific Main Business Overview
11.1.5 Thermo Fisher scientific Latest Developments
11.2 Qiagen
11.2.1 Qiagen Company Information
11.2.2 Qiagen Saliva-based Screening Product Offered
11.2.3 Qiagen Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Qiagen Main Business Overview
11.2.5 Qiagen Latest Developments
11.3 Hologic
11.3.1 Hologic Company Information
11.3.2 Hologic Saliva-based Screening Product Offered
11.3.3 Hologic Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Hologic Main Business Overview
11.3.5 Hologic Latest Developments
11.4 Takara Bio Inc
11.4.1 Takara Bio Inc Company Information
11.4.2 Takara Bio Inc Saliva-based Screening Product Offered
11.4.3 Takara Bio Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Takara Bio Inc Main Business Overview
11.4.5 Takara Bio Inc Latest Developments
11.5 Arcis Biotechnology Limited
11.5.1 Arcis Biotechnology Limited Company Information
11.5.2 Arcis Biotechnology Limited Saliva-based Screening Product Offered
11.5.3 Arcis Biotechnology Limited Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Arcis Biotechnology Limited Main Business Overview
11.5.5 Arcis Biotechnology Limited Latest Developments
11.6 GeneProof
11.6.1 GeneProof Company Information
11.6.2 GeneProof Saliva-based Screening Product Offered
11.6.3 GeneProof Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GeneProof Main Business Overview
11.6.5 GeneProof Latest Developments
11.7 Abacus ALS
11.7.1 Abacus ALS Company Information
11.7.2 Abacus ALS Saliva-based Screening Product Offered
11.7.3 Abacus ALS Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Abacus ALS Main Business Overview
11.7.5 Abacus ALS Latest Developments
11.8 Chai Inc.
11.8.1 Chai Inc. Company Information
11.8.2 Chai Inc. Saliva-based Screening Product Offered
11.8.3 Chai Inc. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Chai Inc. Main Business Overview
11.8.5 Chai Inc. Latest Developments
11.9 Kolplast Group
11.9.1 Kolplast Group Company Information
11.9.2 Kolplast Group Saliva-based Screening Product Offered
11.9.3 Kolplast Group Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Kolplast Group Main Business Overview
11.9.5 Kolplast Group Latest Developments
11.10 Lucence Health INc
11.10.1 Lucence Health INc Company Information
11.10.2 Lucence Health INc Saliva-based Screening Product Offered
11.10.3 Lucence Health INc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Lucence Health INc Main Business Overview
11.10.5 Lucence Health INc Latest Developments
11.11 Vitagene
11.11.1 Vitagene Company Information
11.11.2 Vitagene Saliva-based Screening Product Offered
11.11.3 Vitagene Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Vitagene Main Business Overview
11.11.5 Vitagene Latest Developments
11.12 Therma Bright Inc
11.12.1 Therma Bright Inc Company Information
11.12.2 Therma Bright Inc Saliva-based Screening Product Offered
11.12.3 Therma Bright Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Therma Bright Inc Main Business Overview
11.12.5 Therma Bright Inc Latest Developments
11.13 ACON Laboratories, Inc
11.13.1 ACON Laboratories, Inc Company Information
11.13.2 ACON Laboratories, Inc Saliva-based Screening Product Offered
11.13.3 ACON Laboratories, Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 ACON Laboratories, Inc Main Business Overview
11.13.5 ACON Laboratories, Inc Latest Developments
11.14 TODA PHARMA
11.14.1 TODA PHARMA Company Information
11.14.2 TODA PHARMA Saliva-based Screening Product Offered
11.14.3 TODA PHARMA Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 TODA PHARMA Main Business Overview
11.14.5 TODA PHARMA Latest Developments
11.15 Norgen Biotek Corp.
11.15.1 Norgen Biotek Corp. Company Information
11.15.2 Norgen Biotek Corp. Saliva-based Screening Product Offered
11.15.3 Norgen Biotek Corp. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Norgen Biotek Corp. Main Business Overview
11.15.5 Norgen Biotek Corp. Latest Developments
11.16 Assure Tech. (Hangzhou) Co., Ltd
11.16.1 Assure Tech. (Hangzhou) Co., Ltd Company Information
11.16.2 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product Offered
11.16.3 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Assure Tech. (Hangzhou) Co., Ltd Main Business Overview
11.16.5 Assure Tech. (Hangzhou) Co., Ltd Latest Developments
11.17 Beijing Hotgen Biotech Co., Ltd
11.17.1 Beijing Hotgen Biotech Co., Ltd Company Information
11.17.2 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product Offered
11.17.3 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Beijing Hotgen Biotech Co., Ltd Main Business Overview
11.17.5 Beijing Hotgen Biotech Co., Ltd Latest Developments
11.18 Nantong Diagnos Biotechnology Co., Ltd
11.18.1 Nantong Diagnos Biotechnology Co., Ltd Company Information
11.18.2 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product Offered
11.18.3 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Nantong Diagnos Biotechnology Co., Ltd Main Business Overview
11.18.5 Nantong Diagnos Biotechnology Co., Ltd Latest Developments
11.19 NeuMoDx Molecular, Inc.
11.19.1 NeuMoDx Molecular, Inc. Company Information
11.19.2 NeuMoDx Molecular, Inc. Saliva-based Screening Product Offered
11.19.3 NeuMoDx Molecular, Inc. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 NeuMoDx Molecular, Inc. Main Business Overview
11.19.5 NeuMoDx Molecular, Inc. Latest Developments
11.20 KYODO INTERNATIONAL INC.
11.20.1 KYODO INTERNATIONAL INC. Company Information
11.20.2 KYODO INTERNATIONAL INC. Saliva-based Screening Product Offered
11.20.3 KYODO INTERNATIONAL INC. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 KYODO INTERNATIONAL INC. Main Business Overview
11.20.5 KYODO INTERNATIONAL INC. Latest Developments
11.21 Canvax
11.21.1 Canvax Company Information
11.21.2 Canvax Saliva-based Screening Product Offered
11.21.3 Canvax Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Canvax Main Business Overview
11.21.5 Canvax Latest Developments
11.22 Zymo Research Corporation.
11.22.1 Zymo Research Corporation. Company Information
11.22.2 Zymo Research Corporation. Saliva-based Screening Product Offered
11.22.3 Zymo Research Corporation. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Zymo Research Corporation. Main Business Overview
11.22.5 Zymo Research Corporation. Latest Developments
11.23 Salimetrics
11.23.1 Salimetrics Company Information
11.23.2 Salimetrics Saliva-based Screening Product Offered
11.23.3 Salimetrics Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Salimetrics Main Business Overview
11.23.5 Salimetrics Latest Developments
11.24 NEST Scientific USA
11.24.1 NEST Scientific USA Company Information
11.24.2 NEST Scientific USA Saliva-based Screening Product Offered
11.24.3 NEST Scientific USA Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 NEST Scientific USA Main Business Overview
11.24.5 NEST Scientific USA Latest Developments
11.25 Miraclean Technology Co. Ltd
11.25.1 Miraclean Technology Co. Ltd Company Information
11.25.2 Miraclean Technology Co. Ltd Saliva-based Screening Product Offered
11.25.3 Miraclean Technology Co. Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Miraclean Technology Co. Ltd Main Business Overview
11.25.5 Miraclean Technology Co. Ltd Latest Developments
11.26 Mawi DNA Technologies
11.26.1 Mawi DNA Technologies Company Information
11.26.2 Mawi DNA Technologies Saliva-based Screening Product Offered
11.26.3 Mawi DNA Technologies Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Mawi DNA Technologies Main Business Overview
11.26.5 Mawi DNA Technologies Latest Developments
11.27 Cell Projects Ltd.
11.27.1 Cell Projects Ltd. Company Information
11.27.2 Cell Projects Ltd. Saliva-based Screening Product Offered
11.27.3 Cell Projects Ltd. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.27.4 Cell Projects Ltd. Main Business Overview
11.27.5 Cell Projects Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Saliva-based Screening Market Size 2018-2029
2.1.2 Saliva-based Screening Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Saliva-based Screening Segment by Type
2.2.1 Direct Sample to PCR
2.2.2 RT-qPCR
2.2.3 Lateral Flow Assays
2.3 Saliva-based Screening Market Size by Type
2.3.1 Saliva-based Screening Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Saliva-based Screening Market Size Market Share by Type (2018-2023)
2.4 Saliva-based Screening Segment by Application
2.4.1 Diagnostic Laboratories
2.4.2 Hospitals & Clinics
2.4.3 Others
2.5 Saliva-based Screening Market Size by Application
2.5.1 Saliva-based Screening Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Saliva-based Screening Market Size Market Share by Application (2018-2023)
3 SALIVA-BASED SCREENING MARKET SIZE BY PLAYER
3.1 Saliva-based Screening Market Size Market Share by Players
3.1.1 Global Saliva-based Screening Revenue by Players (2018-2023)
3.1.2 Global Saliva-based Screening Revenue Market Share by Players (2018-2023)
3.2 Global Saliva-based Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SALIVA-BASED SCREENING BY REGIONS
4.1 Saliva-based Screening Market Size by Regions (2018-2023)
4.2 Americas Saliva-based Screening Market Size Growth (2018-2023)
4.3 APAC Saliva-based Screening Market Size Growth (2018-2023)
4.4 Europe Saliva-based Screening Market Size Growth (2018-2023)
4.5 Middle East & Africa Saliva-based Screening Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Saliva-based Screening Market Size by Country (2018-2023)
5.2 Americas Saliva-based Screening Market Size by Type (2018-2023)
5.3 Americas Saliva-based Screening Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Saliva-based Screening Market Size by Region (2018-2023)
6.2 APAC Saliva-based Screening Market Size by Type (2018-2023)
6.3 APAC Saliva-based Screening Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Saliva-based Screening by Country (2018-2023)
7.2 Europe Saliva-based Screening Market Size by Type (2018-2023)
7.3 Europe Saliva-based Screening Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Saliva-based Screening by Region (2018-2023)
8.2 Middle East & Africa Saliva-based Screening Market Size by Type (2018-2023)
8.3 Middle East & Africa Saliva-based Screening Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SALIVA-BASED SCREENING MARKET FORECAST
10.1 Global Saliva-based Screening Forecast by Regions (2024-2029)
10.1.1 Global Saliva-based Screening Forecast by Regions (2024-2029)
10.1.2 Americas Saliva-based Screening Forecast
10.1.3 APAC Saliva-based Screening Forecast
10.1.4 Europe Saliva-based Screening Forecast
10.1.5 Middle East & Africa Saliva-based Screening Forecast
10.2 Americas Saliva-based Screening Forecast by Country (2024-2029)
10.2.1 United States Saliva-based Screening Market Forecast
10.2.2 Canada Saliva-based Screening Market Forecast
10.2.3 Mexico Saliva-based Screening Market Forecast
10.2.4 Brazil Saliva-based Screening Market Forecast
10.3 APAC Saliva-based Screening Forecast by Region (2024-2029)
10.3.1 China Saliva-based Screening Market Forecast
10.3.2 Japan Saliva-based Screening Market Forecast
10.3.3 Korea Saliva-based Screening Market Forecast
10.3.4 Southeast Asia Saliva-based Screening Market Forecast
10.3.5 India Saliva-based Screening Market Forecast
10.3.6 Australia Saliva-based Screening Market Forecast
10.4 Europe Saliva-based Screening Forecast by Country (2024-2029)
10.4.1 Germany Saliva-based Screening Market Forecast
10.4.2 France Saliva-based Screening Market Forecast
10.4.3 UK Saliva-based Screening Market Forecast
10.4.4 Italy Saliva-based Screening Market Forecast
10.4.5 Russia Saliva-based Screening Market Forecast
10.5 Middle East & Africa Saliva-based Screening Forecast by Region (2024-2029)
10.5.1 Egypt Saliva-based Screening Market Forecast
10.5.2 South Africa Saliva-based Screening Market Forecast
10.5.3 Israel Saliva-based Screening Market Forecast
10.5.4 Turkey Saliva-based Screening Market Forecast
10.5.5 GCC Countries Saliva-based Screening Market Forecast
10.6 Global Saliva-based Screening Forecast by Type (2024-2029)
10.7 Global Saliva-based Screening Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher scientific
11.1.1 Thermo Fisher scientific Company Information
11.1.2 Thermo Fisher scientific Saliva-based Screening Product Offered
11.1.3 Thermo Fisher scientific Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Thermo Fisher scientific Main Business Overview
11.1.5 Thermo Fisher scientific Latest Developments
11.2 Qiagen
11.2.1 Qiagen Company Information
11.2.2 Qiagen Saliva-based Screening Product Offered
11.2.3 Qiagen Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Qiagen Main Business Overview
11.2.5 Qiagen Latest Developments
11.3 Hologic
11.3.1 Hologic Company Information
11.3.2 Hologic Saliva-based Screening Product Offered
11.3.3 Hologic Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Hologic Main Business Overview
11.3.5 Hologic Latest Developments
11.4 Takara Bio Inc
11.4.1 Takara Bio Inc Company Information
11.4.2 Takara Bio Inc Saliva-based Screening Product Offered
11.4.3 Takara Bio Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Takara Bio Inc Main Business Overview
11.4.5 Takara Bio Inc Latest Developments
11.5 Arcis Biotechnology Limited
11.5.1 Arcis Biotechnology Limited Company Information
11.5.2 Arcis Biotechnology Limited Saliva-based Screening Product Offered
11.5.3 Arcis Biotechnology Limited Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Arcis Biotechnology Limited Main Business Overview
11.5.5 Arcis Biotechnology Limited Latest Developments
11.6 GeneProof
11.6.1 GeneProof Company Information
11.6.2 GeneProof Saliva-based Screening Product Offered
11.6.3 GeneProof Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GeneProof Main Business Overview
11.6.5 GeneProof Latest Developments
11.7 Abacus ALS
11.7.1 Abacus ALS Company Information
11.7.2 Abacus ALS Saliva-based Screening Product Offered
11.7.3 Abacus ALS Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Abacus ALS Main Business Overview
11.7.5 Abacus ALS Latest Developments
11.8 Chai Inc.
11.8.1 Chai Inc. Company Information
11.8.2 Chai Inc. Saliva-based Screening Product Offered
11.8.3 Chai Inc. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Chai Inc. Main Business Overview
11.8.5 Chai Inc. Latest Developments
11.9 Kolplast Group
11.9.1 Kolplast Group Company Information
11.9.2 Kolplast Group Saliva-based Screening Product Offered
11.9.3 Kolplast Group Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Kolplast Group Main Business Overview
11.9.5 Kolplast Group Latest Developments
11.10 Lucence Health INc
11.10.1 Lucence Health INc Company Information
11.10.2 Lucence Health INc Saliva-based Screening Product Offered
11.10.3 Lucence Health INc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Lucence Health INc Main Business Overview
11.10.5 Lucence Health INc Latest Developments
11.11 Vitagene
11.11.1 Vitagene Company Information
11.11.2 Vitagene Saliva-based Screening Product Offered
11.11.3 Vitagene Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Vitagene Main Business Overview
11.11.5 Vitagene Latest Developments
11.12 Therma Bright Inc
11.12.1 Therma Bright Inc Company Information
11.12.2 Therma Bright Inc Saliva-based Screening Product Offered
11.12.3 Therma Bright Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Therma Bright Inc Main Business Overview
11.12.5 Therma Bright Inc Latest Developments
11.13 ACON Laboratories, Inc
11.13.1 ACON Laboratories, Inc Company Information
11.13.2 ACON Laboratories, Inc Saliva-based Screening Product Offered
11.13.3 ACON Laboratories, Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 ACON Laboratories, Inc Main Business Overview
11.13.5 ACON Laboratories, Inc Latest Developments
11.14 TODA PHARMA
11.14.1 TODA PHARMA Company Information
11.14.2 TODA PHARMA Saliva-based Screening Product Offered
11.14.3 TODA PHARMA Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 TODA PHARMA Main Business Overview
11.14.5 TODA PHARMA Latest Developments
11.15 Norgen Biotek Corp.
11.15.1 Norgen Biotek Corp. Company Information
11.15.2 Norgen Biotek Corp. Saliva-based Screening Product Offered
11.15.3 Norgen Biotek Corp. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Norgen Biotek Corp. Main Business Overview
11.15.5 Norgen Biotek Corp. Latest Developments
11.16 Assure Tech. (Hangzhou) Co., Ltd
11.16.1 Assure Tech. (Hangzhou) Co., Ltd Company Information
11.16.2 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product Offered
11.16.3 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Assure Tech. (Hangzhou) Co., Ltd Main Business Overview
11.16.5 Assure Tech. (Hangzhou) Co., Ltd Latest Developments
11.17 Beijing Hotgen Biotech Co., Ltd
11.17.1 Beijing Hotgen Biotech Co., Ltd Company Information
11.17.2 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product Offered
11.17.3 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Beijing Hotgen Biotech Co., Ltd Main Business Overview
11.17.5 Beijing Hotgen Biotech Co., Ltd Latest Developments
11.18 Nantong Diagnos Biotechnology Co., Ltd
11.18.1 Nantong Diagnos Biotechnology Co., Ltd Company Information
11.18.2 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product Offered
11.18.3 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Nantong Diagnos Biotechnology Co., Ltd Main Business Overview
11.18.5 Nantong Diagnos Biotechnology Co., Ltd Latest Developments
11.19 NeuMoDx Molecular, Inc.
11.19.1 NeuMoDx Molecular, Inc. Company Information
11.19.2 NeuMoDx Molecular, Inc. Saliva-based Screening Product Offered
11.19.3 NeuMoDx Molecular, Inc. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 NeuMoDx Molecular, Inc. Main Business Overview
11.19.5 NeuMoDx Molecular, Inc. Latest Developments
11.20 KYODO INTERNATIONAL INC.
11.20.1 KYODO INTERNATIONAL INC. Company Information
11.20.2 KYODO INTERNATIONAL INC. Saliva-based Screening Product Offered
11.20.3 KYODO INTERNATIONAL INC. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 KYODO INTERNATIONAL INC. Main Business Overview
11.20.5 KYODO INTERNATIONAL INC. Latest Developments
11.21 Canvax
11.21.1 Canvax Company Information
11.21.2 Canvax Saliva-based Screening Product Offered
11.21.3 Canvax Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Canvax Main Business Overview
11.21.5 Canvax Latest Developments
11.22 Zymo Research Corporation.
11.22.1 Zymo Research Corporation. Company Information
11.22.2 Zymo Research Corporation. Saliva-based Screening Product Offered
11.22.3 Zymo Research Corporation. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Zymo Research Corporation. Main Business Overview
11.22.5 Zymo Research Corporation. Latest Developments
11.23 Salimetrics
11.23.1 Salimetrics Company Information
11.23.2 Salimetrics Saliva-based Screening Product Offered
11.23.3 Salimetrics Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Salimetrics Main Business Overview
11.23.5 Salimetrics Latest Developments
11.24 NEST Scientific USA
11.24.1 NEST Scientific USA Company Information
11.24.2 NEST Scientific USA Saliva-based Screening Product Offered
11.24.3 NEST Scientific USA Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 NEST Scientific USA Main Business Overview
11.24.5 NEST Scientific USA Latest Developments
11.25 Miraclean Technology Co. Ltd
11.25.1 Miraclean Technology Co. Ltd Company Information
11.25.2 Miraclean Technology Co. Ltd Saliva-based Screening Product Offered
11.25.3 Miraclean Technology Co. Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Miraclean Technology Co. Ltd Main Business Overview
11.25.5 Miraclean Technology Co. Ltd Latest Developments
11.26 Mawi DNA Technologies
11.26.1 Mawi DNA Technologies Company Information
11.26.2 Mawi DNA Technologies Saliva-based Screening Product Offered
11.26.3 Mawi DNA Technologies Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Mawi DNA Technologies Main Business Overview
11.26.5 Mawi DNA Technologies Latest Developments
11.27 Cell Projects Ltd.
11.27.1 Cell Projects Ltd. Company Information
11.27.2 Cell Projects Ltd. Saliva-based Screening Product Offered
11.27.3 Cell Projects Ltd. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
11.27.4 Cell Projects Ltd. Main Business Overview
11.27.5 Cell Projects Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Saliva-based Screening Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Direct Sample to PCR
Table 3. Major Players of RT-qPCR
Table 4. Major Players of Lateral Flow Assays
Table 5. Saliva-based Screening Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Saliva-based Screening Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Saliva-based Screening Market Size Market Share by Type (2018-2023)
Table 8. Saliva-based Screening Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Saliva-based Screening Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Saliva-based Screening Market Size Market Share by Application (2018-2023)
Table 11. Global Saliva-based Screening Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Saliva-based Screening Revenue Market Share by Player (2018-2023)
Table 13. Saliva-based Screening Key Players Head office and Products Offered
Table 14. Saliva-based Screening Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Saliva-based Screening Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Saliva-based Screening Market Size Market Share by Regions (2018-2023)
Table 19. Global Saliva-based Screening Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Saliva-based Screening Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Saliva-based Screening Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Saliva-based Screening Market Size Market Share by Country (2018-2023)
Table 23. Americas Saliva-based Screening Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Saliva-based Screening Market Size Market Share by Type (2018-2023)
Table 25. Americas Saliva-based Screening Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Saliva-based Screening Market Size Market Share by Application (2018-2023)
Table 27. APAC Saliva-based Screening Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Saliva-based Screening Market Size Market Share by Region (2018-2023)
Table 29. APAC Saliva-based Screening Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Saliva-based Screening Market Size Market Share by Type (2018-2023)
Table 31. APAC Saliva-based Screening Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Saliva-based Screening Market Size Market Share by Application (2018-2023)
Table 33. Europe Saliva-based Screening Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Saliva-based Screening Market Size Market Share by Country (2018-2023)
Table 35. Europe Saliva-based Screening Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Saliva-based Screening Market Size Market Share by Type (2018-2023)
Table 37. Europe Saliva-based Screening Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Saliva-based Screening Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Saliva-based Screening Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Saliva-based Screening Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Saliva-based Screening Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Saliva-based Screening Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Saliva-based Screening Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Saliva-based Screening Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Saliva-based Screening
Table 46. Key Market Challenges & Risks of Saliva-based Screening
Table 47. Key Industry Trends of Saliva-based Screening
Table 48. Global Saliva-based Screening Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Saliva-based Screening Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Saliva-based Screening Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Saliva-based Screening Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Thermo Fisher scientific Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 53. Thermo Fisher scientific Saliva-based Screening Product Offered
Table 54. Thermo Fisher scientific Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Thermo Fisher scientific Main Business
Table 56. Thermo Fisher scientific Latest Developments
Table 57. Qiagen Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 58. Qiagen Saliva-based Screening Product Offered
Table 59. Qiagen Main Business
Table 60. Qiagen Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Qiagen Latest Developments
Table 62. Hologic Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 63. Hologic Saliva-based Screening Product Offered
Table 64. Hologic Main Business
Table 65. Hologic Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Hologic Latest Developments
Table 67. Takara Bio Inc Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 68. Takara Bio Inc Saliva-based Screening Product Offered
Table 69. Takara Bio Inc Main Business
Table 70. Takara Bio Inc Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Takara Bio Inc Latest Developments
Table 72. Arcis Biotechnology Limited Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 73. Arcis Biotechnology Limited Saliva-based Screening Product Offered
Table 74. Arcis Biotechnology Limited Main Business
Table 75. Arcis Biotechnology Limited Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Arcis Biotechnology Limited Latest Developments
Table 77. GeneProof Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 78. GeneProof Saliva-based Screening Product Offered
Table 79. GeneProof Main Business
Table 80. GeneProof Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. GeneProof Latest Developments
Table 82. Abacus ALS Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 83. Abacus ALS Saliva-based Screening Product Offered
Table 84. Abacus ALS Main Business
Table 85. Abacus ALS Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Abacus ALS Latest Developments
Table 87. Chai Inc. Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 88. Chai Inc. Saliva-based Screening Product Offered
Table 89. Chai Inc. Main Business
Table 90. Chai Inc. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Chai Inc. Latest Developments
Table 92. Kolplast Group Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 93. Kolplast Group Saliva-based Screening Product Offered
Table 94. Kolplast Group Main Business
Table 95. Kolplast Group Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Kolplast Group Latest Developments
Table 97. Lucence Health INc Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 98. Lucence Health INc Saliva-based Screening Product Offered
Table 99. Lucence Health INc Main Business
Table 100. Lucence Health INc Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Lucence Health INc Latest Developments
Table 102. Vitagene Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 103. Vitagene Saliva-based Screening Product Offered
Table 104. Vitagene Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Vitagene Main Business
Table 106. Vitagene Latest Developments
Table 107. Therma Bright Inc Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 108. Therma Bright Inc Saliva-based Screening Product Offered
Table 109. Therma Bright Inc Main Business
Table 110. Therma Bright Inc Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Therma Bright Inc Latest Developments
Table 112. ACON Laboratories, Inc Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 113. ACON Laboratories, Inc Saliva-based Screening Product Offered
Table 114. ACON Laboratories, Inc Main Business
Table 115. ACON Laboratories, Inc Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. ACON Laboratories, Inc Latest Developments
Table 117. TODA PHARMA Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 118. TODA PHARMA Saliva-based Screening Product Offered
Table 119. TODA PHARMA Main Business
Table 120. TODA PHARMA Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. TODA PHARMA Latest Developments
Table 122. Norgen Biotek Corp. Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 123. Norgen Biotek Corp. Saliva-based Screening Product Offered
Table 124. Norgen Biotek Corp. Main Business
Table 125. Norgen Biotek Corp. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Norgen Biotek Corp. Latest Developments
Table 127. Assure Tech. (Hangzhou) Co., Ltd Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 128. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product Offered
Table 129. Assure Tech. (Hangzhou) Co., Ltd Main Business
Table 130. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Assure Tech. (Hangzhou) Co., Ltd Latest Developments
Table 132. Beijing Hotgen Biotech Co., Ltd Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 133. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product Offered
Table 134. Beijing Hotgen Biotech Co., Ltd Main Business
Table 135. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Beijing Hotgen Biotech Co., Ltd Latest Developments
Table 137. Nantong Diagnos Biotechnology Co., Ltd Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 138. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product Offered
Table 139. Nantong Diagnos Biotechnology Co., Ltd Main Business
Table 140. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Nantong Diagnos Biotechnology Co., Ltd Latest Developments
Table 142. NeuMoDx Molecular, Inc. Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 143. NeuMoDx Molecular, Inc. Saliva-based Screening Product Offered
Table 144. NeuMoDx Molecular, Inc. Main Business
Table 145. NeuMoDx Molecular, Inc. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. NeuMoDx Molecular, Inc. Latest Developments
Table 147. KYODO INTERNATIONAL INC. Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 148. KYODO INTERNATIONAL INC. Saliva-based Screening Product Offered
Table 149. KYODO INTERNATIONAL INC. Main Business
Table 150. KYODO INTERNATIONAL INC. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. KYODO INTERNATIONAL INC. Latest Developments
Table 152. Canvax Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 153. Canvax Saliva-based Screening Product Offered
Table 154. Canvax Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 155. Canvax Main Business
Table 156. Canvax Latest Developments
Table 157. Zymo Research Corporation. Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 158. Zymo Research Corporation. Saliva-based Screening Product Offered
Table 159. Zymo Research Corporation. Main Business
Table 160. Zymo Research Corporation. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 161. Zymo Research Corporation. Latest Developments
Table 162. Salimetrics Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 163. Salimetrics Saliva-based Screening Product Offered
Table 164. Salimetrics Main Business
Table 165. Salimetrics Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 166. Salimetrics Latest Developments
Table 167. NEST Scientific USA Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 168. NEST Scientific USA Saliva-based Screening Product Offered
Table 169. NEST Scientific USA Main Business
Table 170. NEST Scientific USA Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 171. NEST Scientific USA Latest Developments
Table 172. Miraclean Technology Co. Ltd Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 173. Miraclean Technology Co. Ltd Saliva-based Screening Product Offered
Table 174. Miraclean Technology Co. Ltd Main Business
Table 175. Miraclean Technology Co. Ltd Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 176. Miraclean Technology Co. Ltd Latest Developments
Table 177. Mawi DNA Technologies Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 178. Mawi DNA Technologies Saliva-based Screening Product Offered
Table 179. Mawi DNA Technologies Main Business
Table 180. Mawi DNA Technologies Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 181. Mawi DNA Technologies Latest Developments
Table 182. Cell Projects Ltd. Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 183. Cell Projects Ltd. Saliva-based Screening Product Offered
Table 184. Cell Projects Ltd. Main Business
Table 185. Cell Projects Ltd. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 186. Cell Projects Ltd. Latest Developments
Table 1. Saliva-based Screening Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Direct Sample to PCR
Table 3. Major Players of RT-qPCR
Table 4. Major Players of Lateral Flow Assays
Table 5. Saliva-based Screening Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Saliva-based Screening Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Saliva-based Screening Market Size Market Share by Type (2018-2023)
Table 8. Saliva-based Screening Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Saliva-based Screening Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Saliva-based Screening Market Size Market Share by Application (2018-2023)
Table 11. Global Saliva-based Screening Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Saliva-based Screening Revenue Market Share by Player (2018-2023)
Table 13. Saliva-based Screening Key Players Head office and Products Offered
Table 14. Saliva-based Screening Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Saliva-based Screening Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Saliva-based Screening Market Size Market Share by Regions (2018-2023)
Table 19. Global Saliva-based Screening Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Saliva-based Screening Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Saliva-based Screening Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Saliva-based Screening Market Size Market Share by Country (2018-2023)
Table 23. Americas Saliva-based Screening Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Saliva-based Screening Market Size Market Share by Type (2018-2023)
Table 25. Americas Saliva-based Screening Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Saliva-based Screening Market Size Market Share by Application (2018-2023)
Table 27. APAC Saliva-based Screening Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Saliva-based Screening Market Size Market Share by Region (2018-2023)
Table 29. APAC Saliva-based Screening Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Saliva-based Screening Market Size Market Share by Type (2018-2023)
Table 31. APAC Saliva-based Screening Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Saliva-based Screening Market Size Market Share by Application (2018-2023)
Table 33. Europe Saliva-based Screening Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Saliva-based Screening Market Size Market Share by Country (2018-2023)
Table 35. Europe Saliva-based Screening Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Saliva-based Screening Market Size Market Share by Type (2018-2023)
Table 37. Europe Saliva-based Screening Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Saliva-based Screening Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Saliva-based Screening Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Saliva-based Screening Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Saliva-based Screening Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Saliva-based Screening Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Saliva-based Screening Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Saliva-based Screening Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Saliva-based Screening
Table 46. Key Market Challenges & Risks of Saliva-based Screening
Table 47. Key Industry Trends of Saliva-based Screening
Table 48. Global Saliva-based Screening Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Saliva-based Screening Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Saliva-based Screening Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Saliva-based Screening Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Thermo Fisher scientific Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 53. Thermo Fisher scientific Saliva-based Screening Product Offered
Table 54. Thermo Fisher scientific Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Thermo Fisher scientific Main Business
Table 56. Thermo Fisher scientific Latest Developments
Table 57. Qiagen Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 58. Qiagen Saliva-based Screening Product Offered
Table 59. Qiagen Main Business
Table 60. Qiagen Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Qiagen Latest Developments
Table 62. Hologic Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 63. Hologic Saliva-based Screening Product Offered
Table 64. Hologic Main Business
Table 65. Hologic Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Hologic Latest Developments
Table 67. Takara Bio Inc Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 68. Takara Bio Inc Saliva-based Screening Product Offered
Table 69. Takara Bio Inc Main Business
Table 70. Takara Bio Inc Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Takara Bio Inc Latest Developments
Table 72. Arcis Biotechnology Limited Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 73. Arcis Biotechnology Limited Saliva-based Screening Product Offered
Table 74. Arcis Biotechnology Limited Main Business
Table 75. Arcis Biotechnology Limited Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Arcis Biotechnology Limited Latest Developments
Table 77. GeneProof Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 78. GeneProof Saliva-based Screening Product Offered
Table 79. GeneProof Main Business
Table 80. GeneProof Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. GeneProof Latest Developments
Table 82. Abacus ALS Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 83. Abacus ALS Saliva-based Screening Product Offered
Table 84. Abacus ALS Main Business
Table 85. Abacus ALS Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Abacus ALS Latest Developments
Table 87. Chai Inc. Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 88. Chai Inc. Saliva-based Screening Product Offered
Table 89. Chai Inc. Main Business
Table 90. Chai Inc. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Chai Inc. Latest Developments
Table 92. Kolplast Group Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 93. Kolplast Group Saliva-based Screening Product Offered
Table 94. Kolplast Group Main Business
Table 95. Kolplast Group Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Kolplast Group Latest Developments
Table 97. Lucence Health INc Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 98. Lucence Health INc Saliva-based Screening Product Offered
Table 99. Lucence Health INc Main Business
Table 100. Lucence Health INc Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Lucence Health INc Latest Developments
Table 102. Vitagene Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 103. Vitagene Saliva-based Screening Product Offered
Table 104. Vitagene Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Vitagene Main Business
Table 106. Vitagene Latest Developments
Table 107. Therma Bright Inc Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 108. Therma Bright Inc Saliva-based Screening Product Offered
Table 109. Therma Bright Inc Main Business
Table 110. Therma Bright Inc Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Therma Bright Inc Latest Developments
Table 112. ACON Laboratories, Inc Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 113. ACON Laboratories, Inc Saliva-based Screening Product Offered
Table 114. ACON Laboratories, Inc Main Business
Table 115. ACON Laboratories, Inc Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. ACON Laboratories, Inc Latest Developments
Table 117. TODA PHARMA Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 118. TODA PHARMA Saliva-based Screening Product Offered
Table 119. TODA PHARMA Main Business
Table 120. TODA PHARMA Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. TODA PHARMA Latest Developments
Table 122. Norgen Biotek Corp. Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 123. Norgen Biotek Corp. Saliva-based Screening Product Offered
Table 124. Norgen Biotek Corp. Main Business
Table 125. Norgen Biotek Corp. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Norgen Biotek Corp. Latest Developments
Table 127. Assure Tech. (Hangzhou) Co., Ltd Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 128. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product Offered
Table 129. Assure Tech. (Hangzhou) Co., Ltd Main Business
Table 130. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Assure Tech. (Hangzhou) Co., Ltd Latest Developments
Table 132. Beijing Hotgen Biotech Co., Ltd Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 133. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product Offered
Table 134. Beijing Hotgen Biotech Co., Ltd Main Business
Table 135. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Beijing Hotgen Biotech Co., Ltd Latest Developments
Table 137. Nantong Diagnos Biotechnology Co., Ltd Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 138. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product Offered
Table 139. Nantong Diagnos Biotechnology Co., Ltd Main Business
Table 140. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Nantong Diagnos Biotechnology Co., Ltd Latest Developments
Table 142. NeuMoDx Molecular, Inc. Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 143. NeuMoDx Molecular, Inc. Saliva-based Screening Product Offered
Table 144. NeuMoDx Molecular, Inc. Main Business
Table 145. NeuMoDx Molecular, Inc. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. NeuMoDx Molecular, Inc. Latest Developments
Table 147. KYODO INTERNATIONAL INC. Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 148. KYODO INTERNATIONAL INC. Saliva-based Screening Product Offered
Table 149. KYODO INTERNATIONAL INC. Main Business
Table 150. KYODO INTERNATIONAL INC. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. KYODO INTERNATIONAL INC. Latest Developments
Table 152. Canvax Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 153. Canvax Saliva-based Screening Product Offered
Table 154. Canvax Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 155. Canvax Main Business
Table 156. Canvax Latest Developments
Table 157. Zymo Research Corporation. Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 158. Zymo Research Corporation. Saliva-based Screening Product Offered
Table 159. Zymo Research Corporation. Main Business
Table 160. Zymo Research Corporation. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 161. Zymo Research Corporation. Latest Developments
Table 162. Salimetrics Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 163. Salimetrics Saliva-based Screening Product Offered
Table 164. Salimetrics Main Business
Table 165. Salimetrics Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 166. Salimetrics Latest Developments
Table 167. NEST Scientific USA Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 168. NEST Scientific USA Saliva-based Screening Product Offered
Table 169. NEST Scientific USA Main Business
Table 170. NEST Scientific USA Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 171. NEST Scientific USA Latest Developments
Table 172. Miraclean Technology Co. Ltd Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 173. Miraclean Technology Co. Ltd Saliva-based Screening Product Offered
Table 174. Miraclean Technology Co. Ltd Main Business
Table 175. Miraclean Technology Co. Ltd Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 176. Miraclean Technology Co. Ltd Latest Developments
Table 177. Mawi DNA Technologies Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 178. Mawi DNA Technologies Saliva-based Screening Product Offered
Table 179. Mawi DNA Technologies Main Business
Table 180. Mawi DNA Technologies Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 181. Mawi DNA Technologies Latest Developments
Table 182. Cell Projects Ltd. Details, Company Type, Saliva-based Screening Area Served and Its Competitors
Table 183. Cell Projects Ltd. Saliva-based Screening Product Offered
Table 184. Cell Projects Ltd. Main Business
Table 185. Cell Projects Ltd. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 186. Cell Projects Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Saliva-based Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Saliva-based Screening Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Saliva-based Screening Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Saliva-based Screening Sales Market Share by Country/Region (2022)
Figure 8. Saliva-based Screening Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Saliva-based Screening Market Size Market Share by Type in 2022
Figure 10. Saliva-based Screening in Diagnostic Laboratories
Figure 11. Global Saliva-based Screening Market: Diagnostic Laboratories (2018-2023) & ($ Millions)
Figure 12. Saliva-based Screening in Hospitals & Clinics
Figure 13. Global Saliva-based Screening Market: Hospitals & Clinics (2018-2023) & ($ Millions)
Figure 14. Saliva-based Screening in Others
Figure 15. Global Saliva-based Screening Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Saliva-based Screening Market Size Market Share by Application in 2022
Figure 17. Global Saliva-based Screening Revenue Market Share by Player in 2022
Figure 18. Global Saliva-based Screening Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Saliva-based Screening Market Size 2018-2023 ($ Millions)
Figure 20. APAC Saliva-based Screening Market Size 2018-2023 ($ Millions)
Figure 21. Europe Saliva-based Screening Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Saliva-based Screening Market Size 2018-2023 ($ Millions)
Figure 23. Americas Saliva-based Screening Value Market Share by Country in 2022
Figure 24. United States Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Saliva-based Screening Market Size Market Share by Region in 2022
Figure 29. APAC Saliva-based Screening Market Size Market Share by Type in 2022
Figure 30. APAC Saliva-based Screening Market Size Market Share by Application in 2022
Figure 31. China Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Saliva-based Screening Market Size Market Share by Country in 2022
Figure 38. Europe Saliva-based Screening Market Size Market Share by Type (2018-2023)
Figure 39. Europe Saliva-based Screening Market Size Market Share by Application (2018-2023)
Figure 40. Germany Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Saliva-based Screening Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Saliva-based Screening Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Saliva-based Screening Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 54. APAC Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 55. Europe Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 57. United States Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 58. Canada Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 61. China Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 62. Japan Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 63. Korea Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 65. India Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 66. Australia Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 67. Germany Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 68. France Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 69. UK Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 70. Italy Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 71. Russia Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 72. Spain Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 75. Israel Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 78. Global Saliva-based Screening Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Saliva-based Screening Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Saliva-based Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Saliva-based Screening Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Saliva-based Screening Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Saliva-based Screening Sales Market Share by Country/Region (2022)
Figure 8. Saliva-based Screening Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Saliva-based Screening Market Size Market Share by Type in 2022
Figure 10. Saliva-based Screening in Diagnostic Laboratories
Figure 11. Global Saliva-based Screening Market: Diagnostic Laboratories (2018-2023) & ($ Millions)
Figure 12. Saliva-based Screening in Hospitals & Clinics
Figure 13. Global Saliva-based Screening Market: Hospitals & Clinics (2018-2023) & ($ Millions)
Figure 14. Saliva-based Screening in Others
Figure 15. Global Saliva-based Screening Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Saliva-based Screening Market Size Market Share by Application in 2022
Figure 17. Global Saliva-based Screening Revenue Market Share by Player in 2022
Figure 18. Global Saliva-based Screening Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Saliva-based Screening Market Size 2018-2023 ($ Millions)
Figure 20. APAC Saliva-based Screening Market Size 2018-2023 ($ Millions)
Figure 21. Europe Saliva-based Screening Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Saliva-based Screening Market Size 2018-2023 ($ Millions)
Figure 23. Americas Saliva-based Screening Value Market Share by Country in 2022
Figure 24. United States Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Saliva-based Screening Market Size Market Share by Region in 2022
Figure 29. APAC Saliva-based Screening Market Size Market Share by Type in 2022
Figure 30. APAC Saliva-based Screening Market Size Market Share by Application in 2022
Figure 31. China Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Saliva-based Screening Market Size Market Share by Country in 2022
Figure 38. Europe Saliva-based Screening Market Size Market Share by Type (2018-2023)
Figure 39. Europe Saliva-based Screening Market Size Market Share by Application (2018-2023)
Figure 40. Germany Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Saliva-based Screening Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Saliva-based Screening Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Saliva-based Screening Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Saliva-based Screening Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 54. APAC Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 55. Europe Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 57. United States Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 58. Canada Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 61. China Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 62. Japan Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 63. Korea Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 65. India Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 66. Australia Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 67. Germany Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 68. France Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 69. UK Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 70. Italy Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 71. Russia Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 72. Spain Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 75. Israel Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Saliva-based Screening Market Size 2024-2029 ($ Millions)
Figure 78. Global Saliva-based Screening Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Saliva-based Screening Market Size Market Share Forecast by Application (2024-2029)
